Molecular Docking-Based Insights Into The Antifungal Potential Of Turmerone: Mechanistic Evaluation Of Fungal Enzyme Inhibition
DOI:
https://doi.org/10.52783/jns.v14.3109Keywords:
Turmerone, Molecular docking, Fungal infections, Beta-glucocerebrosidase, Antifungal agentsAbstract
Fungal infections continue to be a major global health threat, necessitating the development of new therapeutic strategies. Turmerone (PubChem ID: 160512), a bioactive compound, has shown promise in several biological activities, yet its antifungal potential remains underexplored. In this study, we evaluated the antifungal activity of Turmerone through molecular docking simulations against three key fungal enzymes: beta-glucocerebrosidase (PDB ID: 9FA3), Demethylase (PDB ID: 6UEZ), and Upc2 (PDB ID: 7VPU), all of which are crucial for fungal cell wall synthesis and metabolism. The docking results revealed that Turmerone exhibited the strongest binding affinity with beta-glucocerebrosidase, with a binding energy of -7.87 kcal/mol (Ki = 1.71 µM). This interaction was facilitated by the formation of hydrogen bonds with the residues LYS-464 and PRO-67, suggesting a stable binding mechanism. For Demethylase, Turmerone demonstrated a binding energy of -6.98 kcal/mol (Ki = 7.70 µM), with significant interactions with the THR-315 residue. In the case of Upc2, the binding energy was -7.15 kcal/mol (Ki = 5.73 µM), with hydrogen bond formation with TYR-724. These results suggest that Turmerone has the potential to inhibit critical enzymes involved in fungal metabolism, positioning it as a promising candidate for antifungal therapy. However, further in vitro and in vivo studies are required to validate its efficacy and safety. This study provides valuable insight into Turmerone's antifungal potential and lays the foundation for future therapeutic development.
Downloads
Metrics
References
Brown GD, Denning DW, Gow NA, et al. Hidden killers: Human fungal infections. Sci Transl Med. 2012;4(165):165rv13.
Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi. 2017;3(4):57.
Denning DW, Bromley MJ. How to bolster the antifungal pipeline. Science. 2015;347(6229):1414–1416.
Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360(6390):739–742.
Perfect JR, Bicanic T. Cryptococcosis diagnosis and treatment: what do we know now. FEMS Yeast Res. 2015;15(5):fov046.
Gow NA, Latge JP, Munro CA. The fungal cell wall: structure, biosynthesis, and function. Microbiol Spectr. 2017;5(3):10.1128.
Monk BC, Goffeau A. Outwitting multidrug resistance to antifungals. Science. 2008;321(5887):367–369.
Cowen LE, Sanglard D, Howard SJ, et al. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med. 2015;5(7):a019752.
Latge JP, Chamilos G. Aspergillus fumigatus and aspergillosis in 2019. Clin Microbiol Rev. 2020;33(1):e00140-18.
Warrilow AG, Melo N, Martel CM, et al. Azole binding properties of Aspergillus fumigatus CYP51: in silico and in vitro interactions with azole antifungals. Antimicrob Agents Chemother. 2010;54(10):4235–4245.
MacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., & Turcotte, B. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrobial agents and chemotherapy, (2005) 49(5), 1745-1752.
Kunnumakkara AB, Bordoloi D, Padmavathi G, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325–1348.
Lim GP, Chu T, Yang F, et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci. 2001;21(21):8370–8377.
Albaqami JJ, Hamdi H, Narayanankutty A, Visakh NU, Sasidharan A, Kuttithodi AM, Famurewa AC, Pathrose B. Chemical Composition and Biological Activities of the Leaf Essential Oils of Curcuma longa, Curcuma aromatica and Curcuma angustifolia. Antibiotics (Basel). 2022 Nov 3;11(11):1547.
Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 17. https://doi.org/10.1186/1758-2946-4-17.
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785-2791. https://doi.org/10.1002/jcc.21256.
BIOVIA, Dassault Systèmes. (2016). Discovery Studio Modeling Environment, Release 2016, San Diego: Dassault Systèmes.
Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455-461.
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013). Curcumin, a component of turmeric: From farm to pharmacy. BioFactors, 39(1), 2-13.
Mishra, S., & Palanivelu, K. (2008). The effect of curcumin (turmeric) on Alzheimer’s disease: An overview. Annals of Indian Academy of Neurology, 11(1), 13-19.
Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., & White, T. C. (2012). Hidden killers: Human fungal infections. Science Translational Medicine, 4(165), 165rv13.
Perfect, J. R. (2017). The antifungal pipeline: A reality check. Nature Reviews Drug Discovery, 16(9), 603-616.
Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer-Aided Drug Design, 7(2), 146-157.
Liu, J., & Rost, B. (2001). Comparing function and structure between entire proteomes. Protein Science, 10(10), 1970-1979.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
